2 withdrawn, 1 completed, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Withdrawn 2, Completed 1, Unknown 1 |
Follow Knee Pain Chronic: new trials by email Literature Review of Knee Pain Chronic trials Research Report on Knee Pain Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed Resiniferatoxin, Placebo - Osteoarthritis, Knee, Osteo Arthritis Knee | Phase 3 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2021-11-09 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee Resiniferatoxin, Placebo - Osteoarthritis, Knee, Knee Pain Chronic | Phase 3 | Withdrawn | Sorrento Therapeutics, Inc. | 2020-12-01 | 2021-11-09 | |
| AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee 4 mL injection of Ampion, 4 mL Injection of Placebo - Osteoarthritis, Knee, Knee Osteoarthritis | Phase 3 | Completed | Ampio Pharmaceuticals. Inc. | 168 | 2017-06-19 | 2022-08-09 |
| Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1% Diclofenac Cream 8%, Diclofenac Gel 1% - Knee Pain Chronic, Knee Injuries | Phase 3 | Unknown | FPR Specialty Pharmacy | 106 | 2014-01-01 | 2014-02-21 |
Osteoarthritis, Knee (3) · Osteoarthritis (2) · Knee Injuries (1)
Arthritis (3) · Joint Diseases (3) · Musculoskeletal Diseases (3) · Rheumatic Diseases (3) · Leg Injuries (1) · Osteoarthritis (1) · Wounds and Injuries (1)
resiniferatoxin (2) · Saline Solution (1)
Sorrento Therapeutics, Inc. (2) · Ampio Pharmaceuticals. Inc. (1) · FPR Specialty Pharmacy (1)
United States (2)
Monica Luchi, MD (2) · Howard Levy, MD (1)